Compound Summary
药名: | acetovanillone |
别名: | FT-0618638; 1-(4-Hydroxy-3-methoxyphenyl)ethanone; Ethanone, 1-(4-hydroxy-3-methoxyphenyl)-; Acetovanillone, >=98%, FG; s2425; 3'-Methoxy-4'-hydroxyacetophenone; AS03910; NSC 209524; STL141075; CCRIS 7285; AC1L1D6F; CHEMBL346919; UNII-B6J7B9UDTR; 4-Acetylguaiacol; bmse010031; NSC-2146; apocynin (acetovanillone); AC1Q46A5; SMR000752909; RL03825; ST50213415; acetovanillone ; NSC2146; MolPort-000-000-274; L911; 3-Methoxy-4-hydroxyacetophenone; 4-hydroxy -3-methoxyacetophenone; AI3-15892; 4-Acetyl-2-methoxyphenol; MLS001304972; 4hydroxy-3-methoxyacetophenone; 4-Hydroxy-3-methoxyphenyl methyl keton; DTXSID7060097; ST24030066; 4'-Hydroxy-3'-methoxyacetophenone; TIMTEC-BB SBB008060; ZINC00162515; 2-methoxy-4-acetylphenol; CM10957; InChI=1/C9H10O3/c1-6(10)7-3-4-8(11)9(5-7)12-2/h3-5,11H,1-2H; Acetophenone, 4'-hydroxy-3'-methoxy-; PubChem3315; WLN: 1VR DQ CO1; 1-(4-hydroxy-3-methoxy-phenyl)-ethanone; Acetovanillon; DB12618; I75; Acetoguaiacon; AC-11656; CS-5647; MFCD00008747; Acetoguaiacone; Acetovanyllon; KS-00000WMF; M-6166; 21432-EP2314295A1; Acetovanillone; Apocynin; BRN 0637373; TR-033392; CHEBI:2781; Acetovanillone; 1-(4-hydroxy-3-methoxyphenyl)-ethanone; HY-N0088; Apocynine; F2191-0004; EINECS 207-854-5; ZINC162515; AURORA KA-3667; LS-13569; SCHEMBL109514; MCULE-4549346345; NSC-209524; AB1003774; KSC236I5L; 4'-Hydroxy-3'-methoxyacetophenone, 98% 50g; 21432-EP2311824A1; AC1Q7AD6; 1-(4-Hydroxy-3-methoxyphenyl)-1-ethanone; 4-Hydroxy-3-methoxyphenyl methyl ketone; DFYRUELUNQRZTB-UHFFFAOYSA-N; FS-3673; Acetovanillone, analytical standard; apocynin; RTR-033392; SC-04834; Acetovanilone; ACETOPHENONE,4-HYDROXY,3-METHOXY ACETOVANILLON; bmse000584; 1-acetyl-4-hydroxy-3-methoxybenzene; BG00601273; NCGC00247065-01; 3-Metoksy-4-hydroksyacetofenon; CJ-02042; AN-4876; 4-HYDROXY-3-METHOXYACETOPHENONE; HMS3651H03; 498-02-2; 4-hydroxy3-methoxyacetophenone; 4-08-00-01814 (Beilstein Handbook Reference); CTK1D6455; I01-7005; 3-Metoksy-4-hydroksyacetofenon [Polish]; ANW-30844; NSC209524; 1-(4-hydroxy-3-methoxy-phenyl)ethanone; BBL009710; AJ-15916; AKOS BBS-00003229; STR03975; 1-(4-hydroxy-3-methoxyphenyl)ethan-1-one; BB_NC-2250; 4CN-0663; AM20090774; Q-200477; Phenol, 4-acetyl-2-methoxy; ACMC-1AHLR; B6J7B9UDTR; C11380; AKOS000120562; AK-42915; SBB008060; KB-47086; AA-504/20839006; 4'-Hydroxy-3'-methoxyacetophenone, 98% |
分子式: | C9H10O3 |
Smiles: | CC(=O)C1=CC(=C(C=C1)O)OC |
成分: | HBIN014429 |
SymMap_id: | SMIT14114 |
TCMID_id: | 117 |
PubChem_id: | 2214 |
植物ID | 拉丁名 | 药用植物名 | 药名 | 来源 | 功能与主治 | 使用民族 |
---|
TCMBANKHE003929 | Radix cynchi atrati;Blackend Swallowwort | 白薇 | To remove heat from blood, to relieve dysuria, and to counteract toxicity and cure sores./See Tylophora ovata . | |||
TCMBANKHE004511 | Gossypium herbaceum | 棉花根 | To relieve cough and calm asthma, free menstruation and relieve pain./Cough, asthma, bronchitis, menstrual disorder, flooding and spotting. | |||
TCMBANKHE008130 | Apocynum androsaemifolium | 点地梅叶茶叶花 | ||||
TCMBANKHE005565 | Apocynum cannabinum | 夹竹桃麻 | ||||
TCMBANKHE005794 | Radix cynchi atrati | 白薇 | To remove heat from blood, to relieve dysuria, and to counteract toxicity and cure sores./See Tylophora ovata . | |||
TCMBANKHE006991 | 胡黄连 | Steaming bone tidal fever due to yin vacuity, night sweating, child gan accumulation, indigestion, abdominal distention and emaciation, dysentery, fever, gastrointestinal damp-heat diarrhea, hemorrhoids. | ||||
TCMBANKHE008835 | Rhizoma cynchi stauntonii | 白前 | 1. To resolve phlegm and stop cough; 2. To conduct qi downward/1. Treatmant of cough due to invasion by exogenous pathogenic factors. Swallowwort rhizome (Baiqian) is used with Schizonepeta (Jingjie) and Platycodon root (Jiegeng) in the formula Zhisuo San. 2. Treatment of turbid phlegm blocking the lungs |
疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
---|
靶点ID | 基因名 | 基因别名 | 描述 |
---|
TCMBANKGE000067 | NCF1 | NCF1A; NOXO2; SH3PXD1A; p47phox | neutrophil cytosolic factor 1 |
TCMBANKGE000225 | TFAM | MTDPS15; MTTF1; MTTFA; TCF6; TCF6L1; TCF6L2; TCF6L3 | transcription factor A, mitochondrial |
TCMBANKGE000245 | CYBB | AMCBX2; CGD; GP91-1; GP91-PHOX; GP91PHOX; IMD34; NOX2; p91-PHOX | cytochrome b-245 beta chain |
TCMBANKGE000295 | FOXO3 | AF6q21; FKHRL1; FKHRL1P2; FOXO2; FOXO3A | forkhead box O3 |
TCMBANKGE000318 | HMGB1 | HMG-1; HMG1; HMG3; SBP-1 | high mobility group box 1 |
TCMBANKGE000321 | NOX4 | KOX; KOX-1; RENOX | NADPH oxidase 4 |
TCMBANKGE000473 | TRPC6 | FSGS2; TRP6 | transient receptor potential cation channel subfamily C member 6 |
TCMBANKGE000646 | DECR1 | DECR; NADPH; SDR18C1 | 2,4-dienoyl-CoA reductase 1 |
TCMBANKGE000739 | NOX5 | - | NADPH oxidase 5 |
TCMBANKGE000740 | NOX1 | GP91-2; MOX1; NOH-1; NOH1 | NADPH oxidase 1 |
TCMBANKGE000759 | MAP1LC3B | ATG8F; LC3B; MAP1A/1BLC3; MAP1LC3B-a | microtubule associated protein 1 light chain 3 beta |
TCMBANKGE000870 | KRT18 | CK-18; CYK18; K18 | keratin 18 |
TCMBANKGE000968 | CYCS | CYC; HCS; THC4 | cytochrome c, somatic |
TCMBANKGE001022 | TJP1 | ZO-1 | tight junction protein 1 |
TCMBANKGE001073 | PTGS2 | COX-2; COX2; GRIPGHS; PGG/HS; PGHS-2; PHS-2; hCox-2 | prostaglandin-endoperoxide synthase 2 |
TCMBANKGE001148 | VEGFA | MVCD1; VEGF; VPF | vascular endothelial growth factor A |
TCMBANKGE001158 | LEP | LEPD; OB; OBS | leptin |
TCMBANKGE001429 | HMG20B | BRAF25; BRAF35; HMGX2; HMGXB2; PP7706; SMARCE1r; SOXL; pp8857 | high mobility group 20B |
TCMBANKGE001697 | MMP1 | CLG; CLGN | matrix metallopeptidase 1 |
TCMBANKGE003906 | SH3PXD2A | FISH; SH3MD1; TKS5 | SH3 and PX domains 2A |
TCMBANKGE004210 | TOX3 | CAGF9; TNRC9 | TOX high mobility group box family member 3 |
TCMBANKGE007597 | NOX3 | GP91-3; MOX-2 | NADPH oxidase 3 |
TCMBANKGE008964 | NCF4 | CGD3; NCF; P40PHOX; SH3PXD4 | neutrophil cytosolic factor 4 |
TCMBANKGE009245 | NOXO1 | P41NOX; P41NOXA; P41NOXB; P41NOXC; SH3PXD5; SNX28 | NADPH oxidase organizer 1 |
TCMBANKGE009644 | HMGB4 | dJ1007G16.5 | high mobility group box 4 |
TCMBANKGE009712 | TOX2 | C20orf100; GCX-1; GCX1; dJ1108D11.2; dJ495O3.1 | TOX high mobility group box family member 2 |
TCMBANKGE010689 | HMG20A | HMGX1; HMGXB1 | high mobility group 20A |
TCMBANKGE011442 | HMGB3 | HMG-2a; HMG-4; HMG2A; HMG4 | high mobility group box 3 |
TCMBANKGE012246 | TLR9 | CD289 | toll like receptor 9 |
TCMBANKGE012728 | SH3PXD2B | FAD49; FTHS; HOFI; KIAA1295; TKS4; TSK4 | SH3 and PX domains 2B |
TCMBANKGE012825 | HMGB2 | HMG2 | high mobility group box 2 |
TCMBANKGE012840 | TOX | TOX1 | thymocyte selection associated high mobility group box |
TCMBANKGE013090 | DUOX2 | LNOX2; NOXEF2; P138-TOX; TDH6; THOX2 | dual oxidase 2 |
TCMBANKGE014206 | ELAVL1 | ELAV1; HUR; Hua; MelG | ELAV like RNA binding protein 1 |
TCMBANKGE014809 | UBTF | CONDBA; NOR-90; UBF; UBF-1; UBF1; UBF2 | upstream binding transcription factor |
TCMBANKGE015054 | DUOX1 | LNOX1; NOXEF1; THOX1 | dual oxidase 1 |